Y-Intercept (HK)’s Beta Bionics BBNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$988K Sell
63,039
-422,815
-87% -$5.03M 0.02% 1061
2026
Q1
$4.87M Buy
485,854
+474,651
+4,237% +$7.02M 0.09% 329
2025
Q4
$341K Buy
+11,203
New +$299K 0.01% 1343

Other funds holding BBNX

Y-Intercept (HK)'s BBNX Position: Q2 2026 in Review

Y-Intercept (HK) reduced its Beta Bionics (BBNX) stake by 87% in Q2 2026, selling an estimated $5.03M and leaving 63,039 shares worth $988K. The position accounts for 0.02% of the portfolio, ranked #1061.

Y-Intercept (HK) first reported a position in BBNX in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.87M in Q1 2026. 19 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Y-Intercept (HK) held 63,039 shares of Beta Bionics worth $988K as of Q2 2026.
  • Y-Intercept (HK) sold 422,815 Beta Bionics shares in Q2 2026, an estimated $5.03M.
  • Beta Bionics made up 0.02% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1061 holding.
  • Y-Intercept (HK) first reported a position in Beta Bionics in Q4 2025 and has held it in 3 quarters since.
  • Y-Intercept (HK)'s Beta Bionics position peaked at $4.87M in Q1 2026.
  • 19 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.